Director Cynthia Flanders completed a significant transaction on January 21, 2026, wherein she sold 19,000 shares of Argan Inc. (NYSE: AGX) common stock, as disclosed in a Form 4 filing submitted to the Securities and Exchange Commission. These shares traded at an average unit price of $386.70, culminating in total proceeds amounting to approximately $7,347,300.
After this sale, Flanders' direct ownership in the company stands at 26,207 shares, reflecting continued personal investment despite the sizable disposition.
Parallel to this insider activity, Argan Inc. released its financial results for the third quarter of fiscal year 2026. The company reported earnings per share (EPS) of $2.17, outperforming the consensus analyst estimate of $1.77. However, the reported revenue was slightly lower than projected, registering at $251.2 million compared to the forecasted $254.53 million. This minor shortfall in revenue did not deter investors entirely; the company’s shares rose by 1.51% in after-hours trading following the earnings announcement.
In response to Argan’s financial disclosures, Goldman Sachs modestly elevated its price target for the company’s stock from $397 to $399, while reaffirming a Buy rating. This update comes amid reports of a 10% miss in revenues and a recent 12% decline in the stock price, highlighting ongoing market volatility.
Further underscoring its commitment to shareholder returns, Argan announced a quarterly dividend increase to $0.50 per share. This represents a 33% uplift over the previous payment and marks the third dividend increment in as many years. Such capital return measures signal continued confidence in Argan’s financial health and future cash flow generation.
Taken together, these developments depict a company navigating modest financial headwinds while maintaining robust earnings performance and a positive stance towards rewarding its shareholders.